Apotex Wins As High Court Denies Pfizer Appeal
The U.S. Supreme Court declined to hear Pfizer Inc.'s appeal in its patent feud with Apotex Inc. over blockbuster blood-pressure drug Norvasc. As a result, an appellate court's March ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article